The 340B Prime Vendor Program Adds AstraZeneca PLC’s Cholesterol-Lowering Medication Crestor(R) to Its List of Branded Drugs Available for Participants

IRVING, TX--(MARKET WIRE)--Aug 1, 2007 -- The 340B Prime Vendor Program, managed by Provista, LLC (formerly known as Healthcare Purchasing Partners, International, LLC), announced today that the cholesterol-lowering statin Crestor® (rosuvastatin calcium) is now available to participants.

MORE ON THIS TOPIC